Epidermal Innervation in Type 1 Diabetic Patients: A 2.5-year prospective study after simultaneous pancreas/kidney transplantation by Boucek, Petr et al.
Epidermal Innervation in Type 1 Diabetic
Patients
A 2.5-year prospective study after simultaneous pancreas/kidney
transplantation
PETR BOUCEK, MD
1
TEREZIA HAVRDOVA, MD
1
LUDEK VOSKA, MD
2
ALENA LODEREROVA, MS
2
LAN HE
3
FRANTISEK SAUDEK, MD
1
KVETOSLAV LIPAR, MD
1
MILOS ADAMEC, MD
1
CLAUDIA SOMMER, MD
3
OBJECTIVE — To assess the effect of normoglycemia following simultaneous pancreas/
kidney transplantation (SPK) on neurological function and intraepidermal nerve ﬁber density
(IENFD) in patients with type 1 diabetes.
RESEARCH DESIGN AND METHODS — We performed vibration perception thresh-
old (VPT) testing and autonomic function testing (AFT) and assessed IENFD in skin biopsies
from the lower thigh and upper calf in 14 healthy control subjects and 18 patients with type 1
diabetes at the time of and at 21–40 (median 29) months post SPK.
RESULTS — At baseline, signiﬁcantly increased VPTs, pathological AFT results, and severe
reductioninIENFDwerepresentinSPKrecipients.AfterSPK,anincreaseofIENFDinthethigh
of more than one epidermal nerve ﬁber per millimeter was noted in three patients (median 4.1,
range 1.9–10.2), but changes were not signiﬁcant for the group as a whole.
CONCLUSIONS — We conclude that either irreversible nerve damage might be present in
some SPK recipients or that longer periods of normoglycemia might be needed to allow nerve
regeneration.
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D
iabetic neuropathy is a common di-
abetes complication that may result
in serious consequences such as
pain, foot ulcers, and amputations. Al-
though optimal glycemic control is con-
sidered an effective preventive measure,
intervention studies in advanced stages of
diabetic neuropathy have been almost
uniformlyunsuccessful(1).Onlyarrestof
progression of diabetic neuropathy could
be achieved in patients after pancreas
transplantation (2). To assess nerve re-
generation following pancreas transplan-
tation, Kennedy et al. (3) proposed the
use of skin biopsies with quantiﬁcation of
intraepidermal nerve ﬁber density
(IENFD). Previously, we documented se-
vere IENFD reduction in lower-limb skin
biopsies performed at the time of pan-
creastransplantation(4).Herewepresent
assessment of IENFD following a mean of
2.5 years of normoglycemia.
RESEARCH DESIGN AND
METHODS— A total of 22 patients
with type 1 diabetes undergoing simulta-
neous pancreas/kidney transplantation
(SPK) and 14 healthy control subjects
participated in the study. For details of
the procedure and study subjects, please
see the online appendix (available at
http://dx.doi.org/10.2337/dc07-2409).
The study was approved by the local eth-
ics committee, and informed consent was
obtained from all subjects.
Skin biopsies were performed using a
3-mm punch (Stiefel Laboratories, Sligo,
Ireland) from the distal thigh (two sam-
ples at a distance of 1 cm, one assessed in
Prague and the other in Wu ¨rzburg) and
theproximalcalf(onesample,assessedin
Prague) at the time of SPK and at 30  5
(mean  SD) months post transplant. Bi-
opsies from control subjects were taken
from corresponding regions. After ﬁxa-
tion(4%paraformaldehydefor3hat4°C,
then cryoprotection with 10% sucrose in
0.1mol/lPBS)andfreezing(inisopentane
cooled by liquid nitrogen), 40-m sec-
tions were immunoreacted with a rabbit
polyclonal antibody to the panaxonal
marker protein gene product (PGP) 9.5
(DakoCytomation, Glostrup, Denmark),
followed by mouse anti-rabbit IgG conju-
gated with rhodamine or Cy3 (Jackson
Immuno Research, West Grove, PA).
Samples were imaged with an Olympus
microscope BX 51 (Olympus Optical,
Hamburg,Germany)inPragueandwitha
Zeiss Axiophot 2 (Carl Zeiss, Go ¨ttingen,
Germany) in Wu ¨rzburg. Three sections
per patient were examined. The mean
number of intraepidermal nerve ﬁbers
(IENFs) per millimeter epidermis was de-
rived using the software Olympus DP-
SOFT (Software Imaging Systems,
Mu ¨nster, Germany) and Image Pro Plus
4.0 (Media Cybernetics, Leiden, Nether-
lands), respectively. Established counting
rules were followed (5). Changes 1
IENF/mm were considered meaningful.
In addition, the subepidermal nerve
plexus was classiﬁed semiquantitatively
in Wu ¨rzburg as “normal,” “reduced,” or
“absent.” Clinical neuropathy evaluation
in the patients included vibration percep-
tion threshold (VPT) tests (Bio-
Thesiometer; Bio-Medical Instrument,
Newbury, OH) and autonomic function
testing (AFT) (VariaPulse TF3; Sima Me-
dia, Olomouc, Czech Republic) (6). The
Mann-Whitney U test and Wilcoxon’s
signed-rank test were used for inter- and
intra-group comparisons, respectively.
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sulin independence and satisfactory renal
graft function was achieved in 18 patients
(male/female 10/8, aged 47  10 years,
with diabetes duration 29  9 years and
P-creatinine 1.3  0.4 mg/dl at follow-up;
onlineappendixTableA1).Atbaseline,sig-
niﬁcantly increased VPTs, reduced AFT re-
sults (online appendix Table A2), and
severe reduction in IENFD in both regions
werepresentinSPKrecipients(Table1and
online appendix Figure A1). At follow-up
21–40 months (median 29) after SPK, in-
creases in IENFD of the thigh samples were
seen in three patients, with results veriﬁed
inbothPragueandWu ¨rzburg(median4.1,
range1.9–10.2IENF/mm).Thesubepider-
mal plexus was reduced or absent in all but
one patient. A change in category from “re-
duced”to“normal”occurredintwopatients
withimprovementofIENFDbutinnoneof
the other patients. No signiﬁcant changes
occurredinneurologicalfunctionorIENFD
of the transplanted group as a whole.
CONCLUSIONS — Previous reports
of neuropathy follow-up in pancreas or
islet transplant recipients were mostly
based on clinical examination, electro-
physiology, and AFT. Most recently, stabi-
lization of electrophysiological parameters
couldbeshownovera6-yearperiodin18
patients with islet transplantation after
kidney transplantation (7). An innovative
noninvasive approach, corneal confocal
microscopy, was proposed by researchers
from Manchester (8). Using this method,
a signiﬁcant improvement of corneal
nerve ﬁber density and length was de-
tected within 6 months of SPK (9).
We did not encounter a similarly sig-
niﬁcant early regenerative response of
lower-limbnerveﬁbersafterSPK.Whilea
typeIIerrorcannotbeexcludedandmore
advanceddiabeticneuropathycouldhave
been present, other reasons may be also
responsible. The length-related pattern of
diabetic neuropathy and varying regener-
ative capacity of nerve ﬁbers from differ-
ent body regions could play a role.
Moreover, the subepidermal plexus from
which epidermal reinnervation should
occur was reduced in most patients. We
observed some improvement of nerve ﬁ-
ber counts in the biopsies from the more
proximal lower-thigh area in three pa-
tients. While this subgroup did not differ
in clinical characteristics including time
from SPK, a still longer period of normo-
glycemia might be needed to achieve
nerve ﬁber regeneration in the lower
limbs of the remaining patients. Of note,
inthecaseofdiabeticnephropathy,rever-
sal of renal lesions was seen after more
than 5 years of normoglycemia following
pancreas transplantation (10).
Irreparable damage of lower-limb
nerves might also be present in some ad-
vancedcases.Althoughgenerallyproduc-
ing an immense improvement of the
recipient’s clinical condition and long-
term prognosis, SPK does not eliminate
risks connected with diabetic neuropa-
thy. Matricali et al. (11) recently reported
on a high rate of Charcot foot complica-
tions at a mean of 1.8 years posttrans-
plant. Foot ulcers and gangrene, while
often co-initiated by vascular disease and
infection, are not uncommon throughout
the postoperative period. Such complica-
tionshaveoccurredin62of200pancreas
transplantation recipients at our center
since 1994.
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Table 1—A1C, VPT, and IENFD (number of IENF per millimeter) in healthy control subjects
andintype1diabeticpatientsatbaselineandat21–40months(median29)ofnormoglycemia
following SPK
Control
subjects
Diabetic subjects
at SPK
Diabetic subjects
post-SPK
n 14 18 18
A1C (%) 5.6  0.3* 8.2  1.4† 5.4  0.5
VPT (volts) 16  5*‡ 34  11 35  11
TP (IENFD) 11.4  4.2*‡ 0.8  1.3 1.6  2.5
TW (IENFD) 8.9  1.8*‡ 0.8  1.5 1.5  3.2
CP (IENFD) 8.0  3.0*‡ 0.4  1.1 0.4  0.8
Data are means  SD. TP, thigh (Prague); TW, thigh (Würzburg); CP, calf (Prague). *P  0.001 for control
vs. diabetic subjects at SPK; †P  0.001 for diabetic subjects at SPK vs. diabetic subjects post-SPK; ‡P 
0.001 for control subjects vs. diabetic subjects post-SPK.
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